Impaired Downregulation Following Erythropoietin Receptor Activation in Non-Small Cell Lung Carcinoma
Open Access
- 12 October 2006
- journal article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 25 (2) , 380-384
Abstract
Recent evidence confirms the presence of erythropoietin receptors on a variety of cancer cells. This has raised concerns about the use of erythropoiesis-stimulating agents in the treatment of cancer-related anemia. Having previously identified expression of functional erythropoietin receptors in a non-small cell lung carcinoma cell line, H838, which activated key signaling pathways in response to erythropoietin stimulation, we now demonstrate impaired downregulation of the erythropoietin receptor in these tumor cells. The erythropoietin receptor is not ubiquitinated following erythropoietin stimulation in this cancer cell line, and there is no turnover of the receptor in either unstimulated or stimulated cells. Compounding this blunted response is impaired SOCS3 induction downstream of erythropoietin stimulation and an extremely delayed SOCS1 response. If this finding in non-small cell lung carcinoma is a widespread phenomenon, then impaired erythropoietin receptor downregulation and degradation in tumor cells has clinical implications for those patients receiving erythropoiesis-stimulating agents for cancer-related anemia.Keywords
This publication has 23 references indexed in Scilit:
- Induction of Signalling in Non-Erythroid Cells by Pharmacological Levels of ErythropoietinNeurodegenerative Diseases, 2006
- Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitroJournal of Neurochemistry, 2006
- Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cellsThe Prostate, 2005
- Erythropoietin hypersensitivity in primary familial and congenital polycythemia: Role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domainBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signallingBiochemical Journal, 2004
- Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivityOncogene, 2003
- Erythropoietin and G-csf Receptors in Human Tumor Cells: Expression and Aspects regarding FunctionalityTumori Journal, 2002
- Erythropoietin Stimulates Proliferation and Interferes with Differentiation of MyoblastsJournal of Biological Chemistry, 2000
- Erythropoietin stimulates proliferation of human renal carcinoma cellsKidney International, 2000
- Erythropoietin receptor mRNA expression in human endothelial cells.Proceedings of the National Academy of Sciences, 1994